marijuana stocks news

PotNetwork Holding, Inc. Subsidiary, Diamond CBD, Brings to Market Tasty Honey Selections Including Featured Premium Organic CBD-Infused Honey Sticks

PotNetwork Holding, Inc. (OTC Pink: POTNis pleased to announce that its wholly owned subsidiary, Diamond CBD, Inc., has enhanced its product line with a delicious selection of premium honey products. Among these new products, the company will have delicious honey packed straws infused with 10mg of pure natural organic CBD.

With the potentially beneficial attributes of both cannabis and honey known for centuries, Diamond CBD’s highly anticipated Infused Honey Sticks may offer a whole new tasty way to enhance wellness and boost the immune system. Comprised of 100% full spectrum CBD and all natural honey, these delicious straws are expected to be a welcomed item providing enthusiasts with a practical and beneficial delivery method of nature’s gifts as revealed in studies in the Asian Pacific Journal of Tropical Biomedicine and available upon the inevitable opening of flu season.

Although THC remains a scheduled substance under current U.S. law, the paradigm is shifting and attitudes are changing towards cannabis as a result of recent research into the endocannabinoid system and the physical role it plays. Containing receptors that naturally respond to cannabinoids, the human body has, in numerous studies, shown to interact favorably, often enhancing the body’s natural ability to fight disease and reduce symptoms.

One of the major ingredients of cannabis, and the source of CBD rich hemp oil, cannabidiol has been formally recognized by the U.S. Patent Office as an “antioxidant and neuroprotectant.” Filed in 1999, and published in 2003, U.S. Patent 6630507 has recognized cannabidiol as an effective antioxidant. Antioxidants are generally useful in the treatment of oxidative diseases and are known for anti-aging effects. Treatment resistant ailments such as Alzheimer’s disease, Parkinson’s disease, and HIV dementia are mentioned in the abstract as potentially treatable with antioxidant CBD. Inflammatory and autoimmune diseases are also noted.

Recently announced, the Company has delivered yet another impressive month of financial and industry growth. For the month of August 2017, Diamond CBD achieved record breaking revenues of $1,764,880.00, which exceeded July revenues by 20.9%.

Second quarter and year-to-date operating results confirm PotNetwork Holding’s revenues maintain strong growth with performance continuing to exceed fiscal 2017 forecasts. With reported revenues of $5,077,625.00 for the first 6 months of fiscal 2017, and a net profit of $369,237.00, the Company concluded the first half of 2017 with a positive net cash flow of $395,009.00. Based on earlier reported financial statements with OTCMarkets, the Company continues on track to exceed its projections established for 2017. As developments evolve, the Company will be prompt with pertinent updates.

About Diamond CBD Inc.: Diamond CBD focuses on the research, development, and multi-national marketing of premium hemp extracts that contain a broad range of cannabinoids and natural hemp derivatives. Diamond CBD’s team consists of hemp industry pioneers and natural product experts, chemists, doctors and scientists, dedicated to producing the finest and purest cannabidiol (CBD) oils. The result is a robust selection considered among the most powerful natural CBD oils, tinctures, edibles, and vape liquids found anywhere. For more information, please visit its website at

About PotNetwork Holding, Inc: PotNetwork Holding, Inc. (OTC Pink: POTN) is a publicly traded company that acts as a holding company for its subsidiaries, First Capital Venture Co., the owner of Diamond CBD, Inc., the maker of Diamond CBD oils.

Safe Harbor Act: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter forward-looking statements, whether as a result of new information, future events or otherwise.

View source version on

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 |
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Organigram Holdings Inc. (OGI) Reports Fourth Quarter Fiscal 2021 Results

Organigram Reports Fourth Quarter Fiscal 2021 Results Organigram Holdings Inc. (NASDAQ: OGI)…

$SRNA Announces Board of Directors Appointments

Surna, Inc. Announces Board of Directors Appointments Surna, Inc. (SRNA), a technology…

Jushi Holdings Inc.(JUSHF) Completes Acquisition of Two California Retail Dispensaries

Jushi Holdings Inc. Completes Acquisition of Two California Retail Dispensaries Jushi Holding…

AbbVie Inc. (ABBV) RINVOQ® (upadacitinib) Receives Health Canada Approval

AbbVie’s RINVOQ® (upadacitinib) Receives Health Canada Approval as the First and Only…